Responsible for the market access and pricing strategy for Takeda´s Neuroscience portfolio in Europe and Canada, including:- assessment and implementation of opportunities to increase patient access (line extensions, indication expansions, geographic expansion)- implementation of price guidance & governance process and coordination business cases with cross-functional stakeholders at country, regional and global level of the organizations - creation of communication material for governmental affairs work to support external environment shaping to improve patient outcomes- coordination and assessment of data requirements and evidence generation options to secure reimbursement

Driving pricing related processes for Oncology portfolio. Main focus on launch products and national price negotiations ("AMNOG") including - strategic support of value dossier preparation for HTA processes- preparation & participation at price negotiations with GKV-SV- contributions to strategic considerations, forecasting, tracking activities and scenario planning

Since January 2019, Shire Deutschland GmbH is part of Takeda.

Driving local market access processes and projects for several pipeline and launch products accross several therapeutic areas in Germany (Hereditary Angioedema, Hemophilia, Ophthalomogy, Lysosomal Storage Diseases, ...)including:- early payer advices- stakeholder awareness projects- healthcare claims data analysis- support creation of value dossiers for national HTA process- national price negotiations- innovative, regional contracting with insurance companies- forecasting, brand planning- launch preparation- market monitorings

focus on:- shape product strategies and prepare launch activities in collaboration with interal stakeholders- pricing relevant input into value dossier for early benefit assessment by national HTA body (G-BA)- preparation and conduction of price negotiations with national payer (GKV-SV)

Development of the international pricing and market access strategy for a specific molecule (ophthalmology)- Member of the global Molecule Lifecycle Team (early development and commercialization planning)- Coordination of market access managers for VA2 in Germany, France, Italy, UK, Canada and the USA- International payer insights generation - Price recommendation for forecasting

- Evaluate German market environment and address local HTA-requirements for clinical development plan in hemophilia and ophthalmology - Payer insights generation - Member of the Erivedge® negotiation team for one round with the GKV-SV- Conception & implementation of pricing strategies in all distribution channels - Forecasting, market monitoring and reporting - Leading internal process optimizations and cross-departmental employee training and development

customer support, order management, dunning procedure, data maintenance, SAP, CRM, project management, EFQM, internal process optimization

3-month internships in different departments at Roche, including Marketing Oncology & Specialty Care, Human Resources, Customer Service, Finance - Controlling as well as additional training, projects and workshops.